NCAM1 and metabolic dysfunction-associated steatotic liver disease: A decline in MAIT, pDCs, in NASH. Plasma NK cells were unchanged in NAFLD/NASH. Plasma CD56 (bright and dim) shows upregulated surface NKG2D receptors. Hepatic and adipocyte resident NK cells were intact.